FGFR1 and neoplasm: In the FGFR1-amplified lung cancer cell line H1581-xenograft mice and FGFR2-amplified GC cell line SNU16-xenograft mice, oral administration of SOMCL-085 for 21 days substantially inhibited tumor growth without loss of body weight.